J&J JNJ began the first-quarter earnings season for the drug and biotech sector with better-than-expected results. J&J’s first-quarter adjusted earnings were $2.77 per share, which rose 2.2% from the ...

As regulators worldwide raise concerns about this once-popular ingredient, talc alternatives have taken their place. But they don’t all look, feel or cost the same.